ClinicalTrials.gg
RecruitingNCT06992895Updated Apr 13, 2026

The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dressing

An interventional study of The visual presentation utilizes a three-dimensional holographic fan device. in Burn Wounds and Burn, sponsored by Ataturk University. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 3 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
3 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 43 studies in Burns with a site in Turkey — 13 open to participants now, 17 under way, none of them phase 3. Burns · Turkey.

Planned enrollment
8th of 33
70 · median 60
Started
2025
with 7 others
No phase
33 of 43
11 open now
Primary completion
2026-05
later than 9 of 16 live
Registered
28th of 43
by date
Lead sponsor
1 of 43
Ataturk University

Among the 43 studies in Burns with a site in Turkey, this one is the 8th largest by planned enrollment of the 33 interventional ones that give a count, is one of 8 that started in 2025, is one of 33 with no phase, reaches primary completion later than 9 of the 16 other live ones, and was the 28th registered.

Burns

906 studies on the registry are indexed under Burns; 165 are open to participants now.

Browse Burns studies →

Open to participants now

13 of the 43 studies in Burns with a site in Turkey are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 87 Burns studies recruiting now, 38 (44%) set no upper age limit and 38 (44%) stop at 75 or younger; 17 take children under 18; 10 take healthy volunteers.

This study: 3 Years to 12 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Burns with a site in Turkey, or all of them as a file.
02

Study summary

The process of dressing burn injuries has been shown to cause both physical and psychological difficulties. In children, this process is particularly associated with intense pain and anxiety. Consequently, in addition to pharmacological interventions, non-pharmacological methods such as distraction are employed. In recent years, the utilization of holograms as a method of alleviating pain has emerged as a novel approach. The employment of these visual illusions has been demonstrated to effectively distract children, thereby providing a means of reducing discomfort. The objective of this thesis is to evaluate the effects of hologram application on pain, anxiety, fear, and vital signs during burn dressing in children.

Read the detailed description

Burns are defined as traumas caused by damage to the skin and subcutaneous tissues caused by heat, chemicals, electricity, or radiation. The severity of these injuries can range from superficial dermal damage to deep tissue loss. Burns inflict physical harm and can also cause significant psychological distress, including anxiety and fear, particularly in children. The administration of dressing procedures during the post-burn treatment process is a particularly challenging aspect for pediatric patients, often accompanied by significant anxiety and discomfort. Consequently, interventions that target both physical and psychological relaxation are necessary during the treatment process.

Among the technologies developed for the purpose of distraction in recent years, hologram fans are particularly noteworthy. The creation of three-dimensional visualizations by hologram fans utilizes LED lights strategically positioned on high-speed rotating propeller blades, resulting in the presentation of realistic images to the viewer, seemingly suspended in the air. This visual illusion has the potential to mitigate the discomfort and anxiety associated with medical procedures, particularly by capturing the attention of children. Research has demonstrated that the presence of hologram enthusiasts during pediatric medical procedures, such as blood draws, has been shown to reduce levels of fear and stress in children. However, the efficacy of these materials in applications requiring extended use and high levels of discomfort, such as burn dressings, remains to be adequately examined through scientific research.

This randomized controlled experimental study will examine the effect of a hologram fan application on pain, anxiety, and fear levels in pediatric burn patients receiving dressing changes. The study will be conducted with children between the ages of 3 and 12 who are receiving burn treatment in the hospital and require dressings. Those who meet the sampling criteria will be randomly assigned to the experimental or control group. The experimental group will receive a hologram fan display during dressing, while the control group will not receive any distracting method. Children in both groups will have their pain, anxiety, and fear levels measured before, during, and after dressing. Additionally, their basic vital signs, such as pulse and respiration, will be recorded during each dressing application.

03

Conditions studied

  • Burn Wounds
  • Burn

Keywords

  • Holography
  • Burns
  • Pain
  • Anxiety
  • Fear
04

Who can participate

Ages eligible
3 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The subject has indicated their willingness to participate in the study. Physical and mental health.
  • The age range of the subjects included in this study was from 3 to 12 years of age.
  • The subject had never previously engaged in the practice of dressing a burn.
  • The presence of only second degree burns
  • Burn percentage is under 10%

Exclusion criteria

Exclusion Criteria:

  • The subject is unwilling or unable to provide or assent (if applicable).
  • The subject has a history of significant physical or mental health disorders that may interfere with participation in the study.
  • The subject is younger than 3 years old or older than 12 years old.
  • The subject has previously engaged in the practice of burn dressing or similar procedures.
  • The presence of burns other than second-degree burns (e.g., first-degree or third-degree burns).
  • The percentage of burn area is greater than 10%.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Hologram fan group

    The technology of hologram fans will be employed in the 3D hologram fan group during the process of burn dressing. This technology utilizes LED lights to create three-dimensional visuals, thereby allowing children to draw their attention to different directions during dressing. Concurrently, scales designed to assess pain, anxiety, and fear will be completed during and immediately following the dressing process. The collection of data will be continued until the calculated number of participants is reached, as determined by the power analysis.

    Device: The visual presentation utilizes a three-dimensional holographic fan device.

  • No intervention
    Control group

    The control group will be subjected to a state of distraction-free environment during the process of burn dressing. The group will undergo standard treatment procedures and will be treated exclusively with conventional methods. Concurrently, scales designed to assess pain, anxiety, and fear will be completed during and immediately following the dressing process. The collection of data will be continued until the calculated number of participants is reached, as determined by the power analysis.

Interventions

  • DeviceThe visual presentation utilizes a three-dimensional holographic fan device.

    This study is among the first to examine the effect of holographic fan technology on pain, anxiety, and fear in children during burn dressing. In comparison with other distraction methods, holographic fans represent a novel technological intervention designed to mitigate pain and anxiety by engaging children's attention through the use of visual illusions. Furthermore, extant studies on the effectiveness of this technology during prolonged and distressing procedures, such as burn dressing, have been found to lack sufficient data.

06

What researchers measure

Primary outcomes

  1. The Wong-Baker Faces Pain Rating Scale:

    Measures the pain levels of children by describing their facial expressions. There are six different facial expressions, the lowest score is 0 and the highest score is 5.

    Time frame: up to 1 hours

Secondary outcomes

  1. Children's Fear Scale (CFS):

    The level of fear is measured based on the change in facial muscle movements in children at the time of fear. The lowest score is 0 and the highest score is 4.

    Time frame: up to 1 hours

Other outcomes

  1. State-Trait Anxiety Inventory for Children /STAI-CH):

    The State Anxiety Scale for Children is a self-report scale that evaluates children's momentary anxiety levels. The scale evaluates state anxiety based on emotions such as nervousness, tension, and uneasiness, and measures children's anxiety levels between 20 and 60 points.

    Time frame: up to 1 hours

07

Study locations

1 of 2 sites recruiting
  • Erzurum Provincial Health Directorate Erzurum City Hospital
    Erzurum, Yakutiye 25040, Turkey (Türkiye)
    Recruiting
  • Erzurum Provincial Health Directorate Erzurum City Hospital
    Erzurum, Yakutiye 25100, Turkey (Türkiye)
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for May 2026, 7 months after the start.

Of 211 non-industry interventional studies with no phase under Burns, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 7 months is below that.

Counting every sponsor, half of 240 studies reached it within 15 months; a quarter within 6 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2025
First posted
May 28, 2025
StartActual
Oct 15, 2025
Primary completionEst.
May 15, 2026
CompletionEst.
Jun 20, 2026
Last update
Apr 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06992895
Lead sponsor
Ataturk University
Responsible party
Muhammet MÜEZZİNOĞLU (Principal Investigator, Ataturk University) — Principal investigator
First posted
May 28, 2025
Start date
Oct 15, 2025
Primary completion
May 15, 2026 (estimated)
Completion
Jun 20, 2026 (estimated)
Last update
Apr 13, 2026

Study contacts

Zeynep KARAMAN ÖZLÜ, PhD
Contact
zynp_krmnzl@hotmail.com
+905434628682
Muhammet MÜEZZİNOĞLU, B.Sc.
Contact
muhammetmuezzinoglu6161@gmail.com
+905334396131

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion